Lenalidomide promotes p53 degradation by inhibiting MDM2 auto-ubiquitination in myelodysplastic syndrome with chromosome 5q deletion
Overview of attention for article published in Oncogene, April 2012
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (84th percentile)
-
High Attention Score compared to outputs of the same age and source (85th percentile)
Readers on
- mendeley
- 71 Mendeley